# Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

> **NCT01300143** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 126 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** TACE
- **OTHER:** TACE+ RTC

## Key facts

- **NCT ID:** NCT01300143
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2018-10-26
- **Final completion:** 2018-10-26
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300143, "Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01300143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*